Ranjit S. Bindra

机构：Yale New Haven Hospital, Johns Hopkins University, Yale University, University of New Haven, Dana-Farber Cancer Institute · ORCID：0000-0002-3255-0467

发表论文 407 篇 · 总被引 9833 次 · h-index 45

代表论文

Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954 (2026 · bioRxiv (Cold Spring Harbor Laboratory))
CellPyAbility: automated image analysis for high-throughput dose-response screening (2026 · Bioinformatics)
Supplementary Table 4 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion (2026)
Supplementary Figure 4 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion (2026)
Supplementary Figure 6 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion (2026)
Supplementary Table 1 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion (2026)